PASCAL for Tricuspid Regurgitation - a European Registry - Trial NCT05328284
Access comprehensive clinical trial information for NCT05328284 through Pure Global AI's free database. This phase not specified trial is sponsored by LMU Klinikum and is currently Recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 1000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
LMU Klinikum
Timeline & Enrollment
N/A
May 05, 2021
May 30, 2024
Primary Outcome
Change of TR severity
Summary
This study aims to investigate the safety and efficacy of the PASCAL leaflet repair system in
 the treatment of tricuspid regurgitation in a commercial use setting including all
 consecutive patients at the participating Centers in an observational fashion.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05328284
Device Trial